首页 > 最新文献

International journal of research in ayurveda and pharmacy最新文献

英文 中文
ACUTE PHARYNGOTONSILLITIS AND ITS MANAGEMENT THROUGH SIDDHA: A REVIEW 急性咽扁桃体炎及其释迦疗法:综述
Pub Date : 2023-10-31 DOI: 10.7897/2277-4343.1405154
M. T. Selvi, R. Deepika, A. Hazel, M. M. Sundaram, R. Meenakumari
Pharyngotonsillitis is the inflammation of pharynx and tonsils characterized by sore throat and fever. Recurrent infections have adverse effects on normal growth and development of the child. It will hamper the quality of life for school going children. Tonsillitis is very common in pediatric practice. There are about 74,55,494 cases of Tonsillitis in India per year. Modern medicine provides symptomatic relief but does not prevent the recurrence and also cause some adverse effects. Moreover, chronic conditions are often treated by tonsillectomy which also shows some complications. So, there is a need to find out a safe and effective remedy which not only relieves the symptoms but also increases wellbeing. It can be traced by unsheathed treasure of Siddha. Tonsillitis can be correlated with virana silethumam in Siddha. This is caused by deranged kabam and raktha thathu due to improper diet, poor oral hygiene and sedentary lifestyle. Siddha literatures depicted various treatment modalities to cure diseases. This paper is an endeavor to highlight the clinical picture of virana silethumam and its management through Siddha.
咽扁桃体炎是咽部和扁桃体的炎症,以咽喉疼痛和发烧为特征。反复感染会对儿童的正常生长发育造成不利影响。它会影响上学儿童的生活质量。扁桃体炎在儿科临床中非常常见。印度每年约有 74,55,494 例扁桃体炎病例。现代医学可缓解症状,但不能防止复发,还会造成一些不良影响。此外,慢性病通常采用扁桃体切除术进行治疗,但也会出现一些并发症。因此,有必要找到一种安全有效的疗法,不仅能缓解症状,还能提高健康水平。这可以从出鞘的释迦宝藏中找到答案。扁桃体炎与 Siddha 中的 virana silethumam 有关。这是由于饮食不当、口腔卫生差和久坐不动的生活方式导致卡巴姆(kabam)和拉克塔(raktha thathu)失调所致。悉达文献描述了各种治疗疾病的方法。本文旨在强调 virana silethumam 的临床表现以及通过 Siddha 进行治疗的方法。
{"title":"ACUTE PHARYNGOTONSILLITIS AND ITS MANAGEMENT THROUGH SIDDHA: A REVIEW","authors":"M. T. Selvi, R. Deepika, A. Hazel, M. M. Sundaram, R. Meenakumari","doi":"10.7897/2277-4343.1405154","DOIUrl":"https://doi.org/10.7897/2277-4343.1405154","url":null,"abstract":"Pharyngotonsillitis is the inflammation of pharynx and tonsils characterized by sore throat and fever. Recurrent infections have adverse effects on normal growth and development of the child. It will hamper the quality of life for school going children. Tonsillitis is very common in pediatric practice. There are about 74,55,494 cases of Tonsillitis in India per year. Modern medicine provides symptomatic relief but does not prevent the recurrence and also cause some adverse effects. Moreover, chronic conditions are often treated by tonsillectomy which also shows some complications. So, there is a need to find out a safe and effective remedy which not only relieves the symptoms but also increases wellbeing. It can be traced by unsheathed treasure of Siddha. Tonsillitis can be correlated with virana silethumam in Siddha. This is caused by deranged kabam and raktha thathu due to improper diet, poor oral hygiene and sedentary lifestyle. Siddha literatures depicted various treatment modalities to cure diseases. This paper is an endeavor to highlight the clinical picture of virana silethumam and its management through Siddha.","PeriodicalId":14253,"journal":{"name":"International journal of research in ayurveda and pharmacy","volume":"28 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139306684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ROLE OF SAINDHAVADI BIDALAKA IN THE MANAGEMENT OF VATAJA ABHISHYANDA (ALLERGIC CONJUNCTIVITIS) Saindhavadi bidalaka 在治疗 Vataja abhishyanda(过敏性结膜炎)中的作用
Pub Date : 2023-10-31 DOI: 10.7897/2277-4343.1405137
Sonam Vasant Nawle, S. Y. Kotangale
In the present age, Allergic Conjunctivitis is the most common eye disease caused due to allergens like dust, pollen from trees and grass, animal dander, chemical scents, etc. The prevalence of allergic Conjunctivitis in India is on the higher side, affecting 15% to 40% of the Indian population and it is observed to be a seasonal disease, i.e., during summer. According to Acharya Sushruta, Abhishyanda (Conjunctivitis) is the root cause of almost all ocular diseases and, if it is not treated priorly, may land in a chronic course, further resulting in developing severe complications such as Adhimantha (Glaucoma) etc. Vataja Abhishyanda can be correlated to Allergic Conjunctivitis. Allergic Conjunctivitis is characterized by itching, burning sensation, watery, mucous, or stringy discharge, mild photophobia, and eye hyperemia. In the present study, according to Acharya Charaka, Saindhavadi Bidalaka was done on the patient having symptoms of Vataja Abhishyanda (Allergic Conjunctivitis) for 7 days. Vata is said to be the predominant dosha of Vataja Abhishyanda (Allergic Conjunctivitis). Saindhavadi Bidalaka has Vataghna properties (pacify Vata dosha); thus, it will reduce the symptoms of Vataja Abhishyanda (Allergic Conjunctivitis). A total of 3 patients of Vataja Abhishyanda (Allergic Conjunctivitis) were treated by Saindhavadi Bidalaka for seven days. The assessment of the condition was done before and after treatment. The result of the study was analyzed by comparing the before and after the completion of the study. The result proves to be significantly effective based on its clinical assessment.
在当今时代,过敏性结膜炎是由灰尘、草木花粉、动物皮屑、化学气味等过敏原引起的最常见的眼部疾病。过敏性结膜炎在印度的发病率较高,占印度人口的 15%至 40%,而且是一种季节性疾病,即在夏季。Acharya Sushruta 认为,Abhishyanda(结膜炎)几乎是所有眼部疾病的根源,如果不事先治疗,可能会发展成慢性病,进一步导致严重的并发症,如 Adhimantha(青光眼)等。Vataja Abhishyanda 可能与过敏性结膜炎有关。过敏性结膜炎的特征是瘙痒、灼热感、水样、粘液或粘稠分泌物、轻度畏光和眼球充血。在本研究中,根据 Acharya Charaka 的说法,对有 Vataja Abhishyanda(过敏性结膜炎)症状的患者进行了为期 7 天的 Saindhavadi Bidalaka 治疗。据说 Vata 是 Vataja Abhishyanda(过敏性结膜炎)的主要病因。Saindhavadi Bidalaka 具有 Vataghna 特性(平息 Vata dosha),因此可以减轻 Vataja Abhishyanda(过敏性结膜炎)的症状。共有 3 名 Vataja Abhishyanda(过敏性结膜炎)患者接受了为期 7 天的 Saindhavadi Bidalaka 治疗。治疗前后对病情进行了评估。研究结果通过比较研究完成前后进行分析。根据临床评估,结果证明疗效显著。
{"title":"ROLE OF SAINDHAVADI BIDALAKA IN THE MANAGEMENT OF VATAJA ABHISHYANDA (ALLERGIC CONJUNCTIVITIS)","authors":"Sonam Vasant Nawle, S. Y. Kotangale","doi":"10.7897/2277-4343.1405137","DOIUrl":"https://doi.org/10.7897/2277-4343.1405137","url":null,"abstract":"In the present age, Allergic Conjunctivitis is the most common eye disease caused due to allergens like dust, pollen from trees and grass, animal dander, chemical scents, etc. The prevalence of allergic Conjunctivitis in India is on the higher side, affecting 15% to 40% of the Indian population and it is observed to be a seasonal disease, i.e., during summer. According to Acharya Sushruta, Abhishyanda (Conjunctivitis) is the root cause of almost all ocular diseases and, if it is not treated priorly, may land in a chronic course, further resulting in developing severe complications such as Adhimantha (Glaucoma) etc. Vataja Abhishyanda can be correlated to Allergic Conjunctivitis. Allergic Conjunctivitis is characterized by itching, burning sensation, watery, mucous, or stringy discharge, mild photophobia, and eye hyperemia. In the present study, according to Acharya Charaka, Saindhavadi Bidalaka was done on the patient having symptoms of Vataja Abhishyanda (Allergic Conjunctivitis) for 7 days. Vata is said to be the predominant dosha of Vataja Abhishyanda (Allergic Conjunctivitis). Saindhavadi Bidalaka has Vataghna properties (pacify Vata dosha); thus, it will reduce the symptoms of Vataja Abhishyanda (Allergic Conjunctivitis). A total of 3 patients of Vataja Abhishyanda (Allergic Conjunctivitis) were treated by Saindhavadi Bidalaka for seven days. The assessment of the condition was done before and after treatment. The result of the study was analyzed by comparing the before and after the completion of the study. The result proves to be significantly effective based on its clinical assessment.","PeriodicalId":14253,"journal":{"name":"International journal of research in ayurveda and pharmacy","volume":"29 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139307244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CONCEPTUAL ANALYSIS OF AKSHI-TARPANA AND ITS ROLE IN MYOPIA: A REVIEW Akshi-tarpana 的概念分析及其在近视中的作用:综述
Pub Date : 2023-10-31 DOI: 10.7897/2277-4343.1405150
Atul Kumar Ahirwar, Ruby Kumar
Myopia is a refractive error and a major eye health problem with significant social, personal, educational, and economic impacts. Globally, myopia affects 7.9 to 19.7% of the population. It is irreversible in progression and can be corrected with glasses, contact lenses, or refractive surgery. All these treatments are not patient-friendly and are also not the actual solution to the pathology occurring in the eye. The symptoms of myopia closely resemble the disease Timira involving the prathama and dwitiya patala of netra (the eye's anatomical structures). Furthermore, both diseases share similar anatomical structures and pathogenesis. There is a great need to find an ocular procedure to prevent and treat myopia having no or least adverse effects. In Ayurveda, kriyakalpa includes different topical therapeutic procedures for treating eye diseases. Tarpana is one among seven kriyakalpa that not only nourishes the eyeball but cures the diseases of the eye. Preventative and curative effects can be achieved with Tarpana karma for eye diseases. Using a special arrangement, an oily substance (ghrita) is kept in the eye for a predetermined period in Tarpana karma. This article reviews Tarpana karma and its role in myopia prevention and progression.
近视是一种屈光不正,也是一个主要的眼健康问题,对社会、个人、教育和经济都有重大影响。全球有 7.9% 到 19.7% 的人患有近视。近视的发展是不可逆的,可以通过戴眼镜、隐形眼镜或屈光手术来矫正。所有这些治疗方法都不适合患者,也不能真正解决眼部发生的病变。近视眼的症状与涉及眼球解剖结构(netra的prathama和dwitiya patala)的提米拉病(Timira)非常相似。此外,这两种疾病还具有相似的解剖结构和发病机制。因此,亟需找到一种无不良反应或不良反应最小的眼部治疗方法来预防和治疗近视。在阿育吠陀中,kriyakalpa 包括治疗眼疾的各种局部治疗方法。Tarpana 是七种 kriyakalpa 中的一种,它不仅能滋养眼球,还能治疗眼部疾病。使用 Tarpana 卡帕可以达到预防和治疗眼疾的效果。在 Tarpana 卡玛中,使用一种特殊的安排,将一种油性物质(ghrita)在眼睛中保留一段预定的时间。本文回顾了 Tarpana 卡玛及其在近视预防和发展中的作用。
{"title":"CONCEPTUAL ANALYSIS OF AKSHI-TARPANA AND ITS ROLE IN MYOPIA: A REVIEW","authors":"Atul Kumar Ahirwar, Ruby Kumar","doi":"10.7897/2277-4343.1405150","DOIUrl":"https://doi.org/10.7897/2277-4343.1405150","url":null,"abstract":"Myopia is a refractive error and a major eye health problem with significant social, personal, educational, and economic impacts. Globally, myopia affects 7.9 to 19.7% of the population. It is irreversible in progression and can be corrected with glasses, contact lenses, or refractive surgery. All these treatments are not patient-friendly and are also not the actual solution to the pathology occurring in the eye. The symptoms of myopia closely resemble the disease Timira involving the prathama and dwitiya patala of netra (the eye's anatomical structures). Furthermore, both diseases share similar anatomical structures and pathogenesis. There is a great need to find an ocular procedure to prevent and treat myopia having no or least adverse effects. In Ayurveda, kriyakalpa includes different topical therapeutic procedures for treating eye diseases. Tarpana is one among seven kriyakalpa that not only nourishes the eyeball but cures the diseases of the eye. Preventative and curative effects can be achieved with Tarpana karma for eye diseases. Using a special arrangement, an oily substance (ghrita) is kept in the eye for a predetermined period in Tarpana karma. This article reviews Tarpana karma and its role in myopia prevention and progression.","PeriodicalId":14253,"journal":{"name":"International journal of research in ayurveda and pharmacy","volume":"32 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139307384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
VALIDATION OF STABILITY INDICATING RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF GLECAPREVIR AND PIBRENTASVIR BY USING ANALYTICAL QUALITY BY DESIGN (AQBD) METHOD 采用分析质量设计法(AQBD)验证同时估算格列卡韦和匹仑那韦的稳定性指示 RP-HPLC 法
Pub Date : 2023-10-31 DOI: 10.7897/2277-4343.1405140
Nithiyananthan K, P. Kvs
The quantitative measurement of Glecaprevir and Pibrentasvir has been created using a simple, quick, precise, sensitive, and reproducible reverse-phase high-performance liquid chromatography (RP-HPLC) method. It is more difficult to analyse varying amounts of pharmaceutical active medicinal ingredients in dosage forms without interferences. Therefore, the objective of the current work is to estimate Glecaprevir and Pibrentasvir simultaneously by adopting an Analytical Quality by Design (AQbD), a rotatable central composite-based technique using RP-HPLC-based method development and validation. Glecaprevir and Pibrentasvir were separated by chromatography using a Kinetex RP-18 Column (100x4.6mm, 2.6µ) column and a mobile phase made up of Acetonitrile: 0.1% tri fluoro acetic acid in a ratio of 26.464:73.536 v/v. The flow rate was 1.0 ml/min, and a photodiode array detector operating at room temperature was used to detect absorption at 236 nm. ICH criteria have been used to validate the offered techniques' linearity, accuracy, precision, and other attributes. The degradation study's findings showed that the medications deteriorated in high-stress situations. The chemical and pharmaceutical sectors might easily implement this unique AQbD-based analytical technique for routine analysis without any regulatory constraints.
采用一种简单、快速、精确、灵敏且可重复的反相高效液相色谱法(RP-HPLC)对格列卡普韦和匹布伦他韦进行定量检测。要在不产生干扰的情况下分析剂型中不同含量的药物活性成分比较困难。因此,当前工作的目标是通过采用基于 RP-HPLC 方法开发和验证的分析质量设计(AQbD)、可旋转中心复合技术,同时估算格列卡普瑞韦和 Pibrentasvir 的含量。使用 Kinetex RP-18 色谱柱(100x4.6mm,2.6µ)和流动相(乙腈:0.1%三氟乙酸,体积比为 26.464:73.536)对格列卡普韦和皮布那韦进行色谱分离。流速为 1.0 ml/min,光电二极管阵列检测器在室温下工作,检测波长为 236 nm 的吸收。ICH 标准用于验证所提供技术的线性度、准确度、精密度和其他属性。降解研究结果表明,药物在高压力情况下会发生降解。化学和制药行业可以轻松地将这种基于 AQbD 的独特分析技术用于常规分析,而不受任何监管限制。
{"title":"VALIDATION OF STABILITY INDICATING RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF GLECAPREVIR AND PIBRENTASVIR BY USING ANALYTICAL QUALITY BY DESIGN (AQBD) METHOD","authors":"Nithiyananthan K, P. Kvs","doi":"10.7897/2277-4343.1405140","DOIUrl":"https://doi.org/10.7897/2277-4343.1405140","url":null,"abstract":"The quantitative measurement of Glecaprevir and Pibrentasvir has been created using a simple, quick, precise, sensitive, and reproducible reverse-phase high-performance liquid chromatography (RP-HPLC) method. It is more difficult to analyse varying amounts of pharmaceutical active medicinal ingredients in dosage forms without interferences. Therefore, the objective of the current work is to estimate Glecaprevir and Pibrentasvir simultaneously by adopting an Analytical Quality by Design (AQbD), a rotatable central composite-based technique using RP-HPLC-based method development and validation. Glecaprevir and Pibrentasvir were separated by chromatography using a Kinetex RP-18 Column (100x4.6mm, 2.6µ) column and a mobile phase made up of Acetonitrile: 0.1% tri fluoro acetic acid in a ratio of 26.464:73.536 v/v. The flow rate was 1.0 ml/min, and a photodiode array detector operating at room temperature was used to detect absorption at 236 nm. ICH criteria have been used to validate the offered techniques' linearity, accuracy, precision, and other attributes. The degradation study's findings showed that the medications deteriorated in high-stress situations. The chemical and pharmaceutical sectors might easily implement this unique AQbD-based analytical technique for routine analysis without any regulatory constraints.","PeriodicalId":14253,"journal":{"name":"International journal of research in ayurveda and pharmacy","volume":"91 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139308907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A STUDY ON THE DEVELOPMENT AND EVALUATION OF TAMARIND CANDY BY BLENDING WITH DIFFERENT SPICES 通过与不同香料混合开发和评估罗望子糖果的研究
Pub Date : 2023-10-31 DOI: 10.7897/2277-4343.1405136
Sapna Kumari, S. Harti, Komal Chauhan, Medha Kulkarni
The study was done to look into the physicochemical properties of tamarind candy developed from blending different spices. The proximate analysis and the analysis of the antioxidants reveal that the candy contains reasonable amounts, which is beneficial for health. The sample was produced and stored at ambient temperature (43 0C) for 20 days. The colour of the sample was visually observed, and it was found that there was no difference in colour during accelerated storage conditions. The reading for the water activity of fresh candy was 0.344, and the result indicates that water activity was decreased as per the prolonged storage of the sample. The overall acceptability of tamarind candy after 20 days of accelerated storage was good. As per the study, the accelerated ageing test calculation indicates that a product shelf life of more than three months at ambient temperature is acceptable.
这项研究的目的是了解混合不同香料制成的罗望子糖果的理化特性。近似物分析和抗氧化剂分析表明,该糖果含有合理数量的抗氧化剂,对健康有益。样品制作完成后在环境温度(43 摄氏度)下储存 20 天。目测样品的颜色,发现在加速储存条件下颜色没有变化。新鲜糖果的水分活度读数为 0.344,结果表明水分活度随着样品的长期储存而降低。经过 20 天的加速贮藏后,罗望子糖果的总体可接受性良好。根据研究,加速老化试验计算表明,产品在环境温度下的保质期超过三个月是可以接受的。
{"title":"A STUDY ON THE DEVELOPMENT AND EVALUATION OF TAMARIND CANDY BY BLENDING WITH DIFFERENT SPICES","authors":"Sapna Kumari, S. Harti, Komal Chauhan, Medha Kulkarni","doi":"10.7897/2277-4343.1405136","DOIUrl":"https://doi.org/10.7897/2277-4343.1405136","url":null,"abstract":"The study was done to look into the physicochemical properties of tamarind candy developed from blending different spices. The proximate analysis and the analysis of the antioxidants reveal that the candy contains reasonable amounts, which is beneficial for health. The sample was produced and stored at ambient temperature (43 0C) for 20 days. The colour of the sample was visually observed, and it was found that there was no difference in colour during accelerated storage conditions. The reading for the water activity of fresh candy was 0.344, and the result indicates that water activity was decreased as per the prolonged storage of the sample. The overall acceptability of tamarind candy after 20 days of accelerated storage was good. As per the study, the accelerated ageing test calculation indicates that a product shelf life of more than three months at ambient temperature is acceptable.","PeriodicalId":14253,"journal":{"name":"International journal of research in ayurveda and pharmacy","volume":"4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139306477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ANALYSIS OF CHEMICAL CONTAMINANTS IN SEVVIYADHI CHOORANAM Sevviyadhi chooranam 中的化学污染物分析
Pub Date : 2023-10-31 DOI: 10.7897/2277-4343.1405139
S. S, A. N
Aim: The aim of the study was to analyze the chemical contaminants such as heavy metals, aflatoxins and pesticide residues in Siddha polyherbal formulation Sevviyadhi Chooranam, in powder form is indicated for the treatment and management of Sinusitis. Materials and Methods: Sevviyadhi Chooranam, the Siddha polyherbal formulation was prepared as per GMP (Good Manufacturing Practices) guidelines. The formulation was analyzed for heavy metals such as mercury, arsenic, lead and cadmium, aflatoxins such as aflatoxin B1, B2, G1, G2 and pesticide residues such as organochlorine pesticides, organophosphorus pesticides, organo carbamates and pyrethroids at Noble Research Solutions, Kolathur, Chennai. Results: Heavy Metal analysis of SC showed that the presence of Lead about 0.26PPM, Arsenic about 0.61 PPM, Mercury and Cadmium in below detection level. Aflatoxin assay of SC resulted absence of Aflatoxin B1, B2, G1 and G2. Pesticide residue analysis revealed the absence of organochloride pesticides, organophosphorus pesticides, organo carbamates and pyrethroids. Conclusion: The findings of this study revealed the presence of heavy metals such as lead and arsenic in limited amount and absence of mercury and cadmium, and absence of aflatoxins and pesticide residue in the Siddha polyherbal formulation Sevviyadhi chooranam. The study ensured that Sevviyadhi chooranam was free from chemical contaminants such as heavy metals, aflatoxins and pesticide residue and validated the safety of SC for therapeutic usage in treatment of sinusitis.
目的:本研究旨在分析用于治疗和控制鼻窦炎的 Siddha 多草药配方 Sevviyadhi Chooranam(粉末状)中的重金属、黄曲霉毒素和农药残留等化学污染物。材料与方法Siddha 多草药配方 Sevviyadhi Chooranam 是按照 GMP(良好生产规范)准则制备的。在金奈 Kolathur 的 Noble Research Solutions 公司对配方进行了重金属(如汞、砷、铅和镉)、黄曲霉毒素(如黄曲霉毒素 B1、B2、G1、G2)和农药残留(如有机氯农药、有机磷农药、有机氨基甲酸酯和拟除虫菊酯)分析。结果SC 的重金属分析表明,铅含量约为 0.26PPM,砷含量约为 0.61PPM,汞和镉含量低于检测水平。黄曲霉毒素化验结果显示不含黄曲霉毒素 B1、B2、G1 和 G2。农药残留分析表明不含有机氯农药、有机磷农药、有机氨基甲酸酯和拟除虫菊酯。结论研究结果表明,Siddha 多草药配方 Sevviyadhi chooranam 中含有少量重金属,如铅和砷,不含汞和镉,也不含黄曲霉毒素和农药残留。这项研究确保了 Sevviyadhi chooranam 不含重金属、黄曲霉毒素和农药残留等化学污染物,并验证了 SC 用于治疗鼻窦炎的安全性。
{"title":"ANALYSIS OF CHEMICAL CONTAMINANTS IN SEVVIYADHI CHOORANAM","authors":"S. S, A. N","doi":"10.7897/2277-4343.1405139","DOIUrl":"https://doi.org/10.7897/2277-4343.1405139","url":null,"abstract":"Aim: The aim of the study was to analyze the chemical contaminants such as heavy metals, aflatoxins and pesticide residues in Siddha polyherbal formulation Sevviyadhi Chooranam, in powder form is indicated for the treatment and management of Sinusitis. Materials and Methods: Sevviyadhi Chooranam, the Siddha polyherbal formulation was prepared as per GMP (Good Manufacturing Practices) guidelines. The formulation was analyzed for heavy metals such as mercury, arsenic, lead and cadmium, aflatoxins such as aflatoxin B1, B2, G1, G2 and pesticide residues such as organochlorine pesticides, organophosphorus pesticides, organo carbamates and pyrethroids at Noble Research Solutions, Kolathur, Chennai. Results: Heavy Metal analysis of SC showed that the presence of Lead about 0.26PPM, Arsenic about 0.61 PPM, Mercury and Cadmium in below detection level. Aflatoxin assay of SC resulted absence of Aflatoxin B1, B2, G1 and G2. Pesticide residue analysis revealed the absence of organochloride pesticides, organophosphorus pesticides, organo carbamates and pyrethroids. Conclusion: The findings of this study revealed the presence of heavy metals such as lead and arsenic in limited amount and absence of mercury and cadmium, and absence of aflatoxins and pesticide residue in the Siddha polyherbal formulation Sevviyadhi chooranam. The study ensured that Sevviyadhi chooranam was free from chemical contaminants such as heavy metals, aflatoxins and pesticide residue and validated the safety of SC for therapeutic usage in treatment of sinusitis.","PeriodicalId":14253,"journal":{"name":"International journal of research in ayurveda and pharmacy","volume":"31 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139306454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A CASE STUDY ON A COMPLEX FISTULA-IN-ANO BY AYURVEDIC MANAGEMENT 阿育吠陀治疗复杂瘘管一例
Pub Date : 2023-08-31 DOI: 10.7897/2277-4343.1404101
Rahul Kumar Verma, Suman Yadav, Ashutosh Kumar Yadav
Fistula-in-ano can be a complicated disease to manage. An anal fistula is divided into simple and complex fistula. Managing complex fistula is even more challenging, which typically affects younger people and causes persistent morbidity. It is pertinent to define complex anal fistula. From a practical point of view, a fistula that is difficult to manage has a higher risk of recurrence, poses a greater threat to continence and is classified as a complex fistula. Due to its difficulty in treating medically and surgically, Bhagandara (fistula-in-ano) is one of the eight major disorders classified under Astamahagada in Ayurveda. Ayurvedic surgeons frequently use the effective fistula treatment known as Ksharasutra; however, cutting the passage takes a very long time. As a result, this procedure is now sometimes referred to as partial fistulectomy with Ksharasutra ligation, fibrin glue, fistula plug (FP), Fistula-tract Laser Closure (FiLaC), Seton techniques, video-assisted anal fistula treatment (VAAFT), LIFT (ligation of intersphincteric fistulous tract), and IFTAK (interception of fistulous tract with application of Ksharasutra), also known as window technique, where the Guggulu based Apamarg Ksharasutra is placed. This method shortens the healing time and allows repairing such a complicated fistula-in-ano with little tissue injury. Infected anal crypt, secondary extension and related conditions are the key factors that lead to the recurrence of complex anal fistulas. Surgery in complex anal fistula aims to prevent recurrence, avoid incontinence and avoid damaging the sphincter muscles (the ring of muscles that open and close the anus).
瘘管是一种复杂的疾病。肛瘘分为单纯性和复合性肛瘘。管理复杂瘘管更具挑战性,这通常影响年轻人并导致持续发病率。复杂肛瘘的定义是有针对性的。从实用角度来看,难以处理的瘘管复发风险较高,对尿失禁的威胁更大,可归类为复杂瘘管。由于在医学和外科治疗上的困难,Bhagandara(瘘管)是阿育吠陀医学中被归类为Astamahagada的八种主要疾病之一。阿育吠陀外科医生经常使用被称为Ksharasutra的有效瘘管治疗;然而,切割通道需要很长时间。因此,该手术现在有时被称为部分瘘管切除术,使用Ksharasutra结扎、纤维蛋白胶、瘘管塞(FP)、瘘管束激光关闭(FiLaC)、Seton技术、视频辅助肛瘘治疗(VAAFT)、LIFT(括括肌间瘘管结扎)和IFTAK(应用Ksharasutra阻断瘘管束),也称为窗口技术,其中放置基于Guggulu的Apamarg Ksharasutra。这种方法缩短了愈合时间,使修复这种复杂的瘘管的组织损伤很小。肛门隐窝感染、继发扩张及相关条件是导致复杂肛瘘复发的关键因素。复杂肛瘘手术的目的是防止复发,避免失禁,避免损伤括约肌(肛门的开合肌肉环)。
{"title":"A CASE STUDY ON A COMPLEX FISTULA-IN-ANO BY AYURVEDIC MANAGEMENT","authors":"Rahul Kumar Verma, Suman Yadav, Ashutosh Kumar Yadav","doi":"10.7897/2277-4343.1404101","DOIUrl":"https://doi.org/10.7897/2277-4343.1404101","url":null,"abstract":"Fistula-in-ano can be a complicated disease to manage. An anal fistula is divided into simple and complex fistula. Managing complex fistula is even more challenging, which typically affects younger people and causes persistent morbidity. It is pertinent to define complex anal fistula. From a practical point of view, a fistula that is difficult to manage has a higher risk of recurrence, poses a greater threat to continence and is classified as a complex fistula. Due to its difficulty in treating medically and surgically, Bhagandara (fistula-in-ano) is one of the eight major disorders classified under Astamahagada in Ayurveda. Ayurvedic surgeons frequently use the effective fistula treatment known as Ksharasutra; however, cutting the passage takes a very long time. As a result, this procedure is now sometimes referred to as partial fistulectomy with Ksharasutra ligation, fibrin glue, fistula plug (FP), Fistula-tract Laser Closure (FiLaC), Seton techniques, video-assisted anal fistula treatment (VAAFT), LIFT (ligation of intersphincteric fistulous tract), and IFTAK (interception of fistulous tract with application of Ksharasutra), also known as window technique, where the Guggulu based Apamarg Ksharasutra is placed. This method shortens the healing time and allows repairing such a complicated fistula-in-ano with little tissue injury. Infected anal crypt, secondary extension and related conditions are the key factors that lead to the recurrence of complex anal fistulas. Surgery in complex anal fistula aims to prevent recurrence, avoid incontinence and avoid damaging the sphincter muscles (the ring of muscles that open and close the anus).","PeriodicalId":14253,"journal":{"name":"International journal of research in ayurveda and pharmacy","volume":"23 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136035014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
OECD GUIDELINES FOR ACUTE ORAL TOXICITY STUDIES: AN OVERVIEW 经合组织急性口服毒性研究指南:概述
Pub Date : 2023-08-31 DOI: 10.7897/2277-4343.1404130
Gothe Shivani Rameshwar, Pawade Uday Venkatrao, Nikam Ashwin Vithalrao, Anjankar Meghsham Pramodrao
The OECD Guidelines for testing chemicals provide a unique method for assessing the potential impact of chemicals on human health and the environment. These are divided into five sections. Oral toxicity studies are mentioned in the fourth section, i.e. Health Effects. This section cites the guidelines for acute, sub-acute, sub-chronic and chronic oral toxicity studies. Acute oral toxicity refers to those adverse effects of oral administration of a single dose or multiple doses given within 24 hours. OECD guidelines for Acute oral toxicity include 420 (Fixed Dose Procedure), 423 (Acute Toxic Class Method) and 425 (Up-and-Down procedure). OECD guidelines 420, 423 and 425 provide information on the hazardous properties and allow the substance to be ranked and classified according to the Globally Harmonised System (GHS) for the classification of chemicals which cause acute toxicity. In OECD Guideline 423, the method classifies the test substance as one of a series of toxicity classes defined by fixed LD50 cut-off values, while the OECD Guideline 425 method permits estimation of LD50 with a confidence interval. Based on these guidelines, a toxic dose of the drug is obtained. This study aims to compare and highlight the acute oral toxicity guidelines.
经合组织化学品测试准则为评估化学品对人类健康和环境的潜在影响提供了一种独特的方法。它们被分为五个部分。口服毒性研究在第四部分,即健康效应中提到。本节引用了急性、亚急性、亚慢性和慢性口服毒性研究的指南。急性口服毒性是指在24小时内口服单次或多次给药所产生的不良反应。经合组织急性口服毒性指南包括420(固定剂量程序),423(急性毒性分类方法)和425(上下程序)。经合组织指南420、423和425提供了有关危险特性的信息,并允许根据全球协调制度(GHS)对引起急性毒性的化学品进行分类和排序。在OECD指南423中,该方法将测试物质归类为由固定LD50临界值定义的一系列毒性类别之一,而OECD指南425方法允许用置信区间估计LD50。根据这些准则,可以得出药物的毒性剂量。本研究旨在比较和强调急性口服毒性指南。
{"title":"OECD GUIDELINES FOR ACUTE ORAL TOXICITY STUDIES: AN OVERVIEW","authors":"Gothe Shivani Rameshwar, Pawade Uday Venkatrao, Nikam Ashwin Vithalrao, Anjankar Meghsham Pramodrao","doi":"10.7897/2277-4343.1404130","DOIUrl":"https://doi.org/10.7897/2277-4343.1404130","url":null,"abstract":"The OECD Guidelines for testing chemicals provide a unique method for assessing the potential impact of chemicals on human health and the environment. These are divided into five sections. Oral toxicity studies are mentioned in the fourth section, i.e. Health Effects. This section cites the guidelines for acute, sub-acute, sub-chronic and chronic oral toxicity studies. Acute oral toxicity refers to those adverse effects of oral administration of a single dose or multiple doses given within 24 hours. OECD guidelines for Acute oral toxicity include 420 (Fixed Dose Procedure), 423 (Acute Toxic Class Method) and 425 (Up-and-Down procedure). OECD guidelines 420, 423 and 425 provide information on the hazardous properties and allow the substance to be ranked and classified according to the Globally Harmonised System (GHS) for the classification of chemicals which cause acute toxicity. In OECD Guideline 423, the method classifies the test substance as one of a series of toxicity classes defined by fixed LD50 cut-off values, while the OECD Guideline 425 method permits estimation of LD50 with a confidence interval. Based on these guidelines, a toxic dose of the drug is obtained. This study aims to compare and highlight the acute oral toxicity guidelines.","PeriodicalId":14253,"journal":{"name":"International journal of research in ayurveda and pharmacy","volume":"13 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136035225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A REVIEW ON HERBAL MEDICINE IN INDIA: CURRENT MARKET TRENDS AND OPPORTUNITIES 草药在印度的回顾:当前的市场趋势和机遇
Pub Date : 2023-08-31 DOI: 10.7897/2277-4343.1404131
Pooja Rohilla, Jay Prakash Gupta
Herbal medicines have been integral to India's traditional health care systems, especially Ayurveda, for centuries. In recent years, there has been a significant resurgence of interest in herbal medicine both domestically and globally, driven by the growing demand for natural and alternative healthcare solutions. In this study, we are trying to analyse the current market trends and opportunities in India's herbal medicine field. This study aims to have a preliminary understanding of the Indian herbal medicine market, market size, growth prospects, key players, and regulatory framework and also highlights the significant efforts of government ministries towards promoting the Herbal medicine market in India and Abroad. By analysing market trends and consumer preferences, this study offers valuable insights for entrepreneurs, investors, and policymakers looking to tap into the potential of herbal medicine in India.
几个世纪以来,草药一直是印度传统医疗保健体系中不可或缺的一部分,尤其是阿育吠陀。近年来,由于对天然和替代医疗保健解决方案的需求不断增长,国内外对草药的兴趣都有了显著的复苏。在这项研究中,我们试图分析印度草药领域当前的市场趋势和机会。本研究旨在初步了解印度草药市场、市场规模、增长前景、主要参与者和监管框架,并强调政府部门为促进印度和国外草药市场所做的重大努力。通过分析市场趋势和消费者偏好,本研究为希望挖掘印度草药潜力的企业家、投资者和政策制定者提供了有价值的见解。
{"title":"A REVIEW ON HERBAL MEDICINE IN INDIA: CURRENT MARKET TRENDS AND OPPORTUNITIES","authors":"Pooja Rohilla, Jay Prakash Gupta","doi":"10.7897/2277-4343.1404131","DOIUrl":"https://doi.org/10.7897/2277-4343.1404131","url":null,"abstract":"Herbal medicines have been integral to India's traditional health care systems, especially Ayurveda, for centuries. In recent years, there has been a significant resurgence of interest in herbal medicine both domestically and globally, driven by the growing demand for natural and alternative healthcare solutions. In this study, we are trying to analyse the current market trends and opportunities in India's herbal medicine field. This study aims to have a preliminary understanding of the Indian herbal medicine market, market size, growth prospects, key players, and regulatory framework and also highlights the significant efforts of government ministries towards promoting the Herbal medicine market in India and Abroad. By analysing market trends and consumer preferences, this study offers valuable insights for entrepreneurs, investors, and policymakers looking to tap into the potential of herbal medicine in India.","PeriodicalId":14253,"journal":{"name":"International journal of research in ayurveda and pharmacy","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136035534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A CASE STUDY ON DUSTAVRANA 以达斯达瓦拉纳为例
Pub Date : 2023-08-31 DOI: 10.7897/2277-4343.1404102
Mahantesh V Walishettar
Background: Dusta vrana is the severe complication of untreated ulcers caused by varicose vein, Thromboangiitis Obliterans, atherosclerosis, trauma, etc. vrana with poothi gandha, vivarnata, bahu srava, maha ruja is known as dusta vrana. Such ulcers can be managed with Panchakarma chikitsa by following the bahya and abhyantara shodhana management line. Brief case report: A 75 years old male patient came with pain, swelling and ulcer over the left foot for six months with a history of trauma; he was a known case of Thromboangiitis Obliterans, having undergone amputation of 1st, 2nd, and 4th and 5th toes of left lower limb. The patient had a 60-70 % block of distal Anterior tibial artery and dorsalis pedis artery. Bahya shodhana was done by dhara with gomutra, sphatika jala panchavalkala kwatha and abhyantara shodhana by Manjistadi kshara basti in yoga basti pattern. Conclusion: Significant reduction was seen in slough and pain. The appearance of granulation tissue was observed. Sthanika dhara with gomutra, which has ushna, teekshna, and lekhana properties, removes slough and improves local circulation. Sphatika jala does lekhana and shodhana. Panchavalkala kwatha has vrana ropana property. Manjistadi kshara basti does srotoshodhana and enhances circulation by virtue of its kshareeya guna and acts as rakta prasadaka and vrana ropaka.
背景:虚斑是由静脉曲张、血栓闭塞性脉管炎、动脉粥样硬化、外伤等引起的溃疡未经治疗而引起的严重并发症。虚斑与poothi gandha、vivarnata、bahu srava、maha ruja被称为虚斑。这种溃疡可以通过遵循bahya和abhyantara shodhana管理线使用Panchakarma chikitsa进行管理。病例简介:75岁男性患者,因左足疼痛、肿胀、溃疡6个月,有外伤史;他是一名已知的血栓闭塞性脉管炎病例,曾截肢左下肢第一、第二、第四和第五趾。患者胫骨远端前动脉和足背动脉阻滞60- 70%。Bahya shodhana由dhara与gomutra一起完成,sphatika jala panchavalala kwatha和Manjistadi kshara basti以瑜伽模式完成abhyantara shodhana。结论:治疗后疼痛及脱落明显减轻。观察肉芽组织外观。Sthanika dhara with gomutra具有ushna, teekshna和lekhana的特性,可以去除脱皮,改善局部循环。Sphatika jala做lekhana和shodhana。panchavalala kwatha具有vrana ropana属性。Manjistadi kshara basti通过其kshareeya guna和rakta prasadaka和vrana ropaka的作用来进行srotoshodhana和促进循环。
{"title":"A CASE STUDY ON DUSTAVRANA","authors":"Mahantesh V Walishettar","doi":"10.7897/2277-4343.1404102","DOIUrl":"https://doi.org/10.7897/2277-4343.1404102","url":null,"abstract":"Background: Dusta vrana is the severe complication of untreated ulcers caused by varicose vein, Thromboangiitis Obliterans, atherosclerosis, trauma, etc. vrana with poothi gandha, vivarnata, bahu srava, maha ruja is known as dusta vrana. Such ulcers can be managed with Panchakarma chikitsa by following the bahya and abhyantara shodhana management line. Brief case report: A 75 years old male patient came with pain, swelling and ulcer over the left foot for six months with a history of trauma; he was a known case of Thromboangiitis Obliterans, having undergone amputation of 1st, 2nd, and 4th and 5th toes of left lower limb. The patient had a 60-70 % block of distal Anterior tibial artery and dorsalis pedis artery. Bahya shodhana was done by dhara with gomutra, sphatika jala panchavalkala kwatha and abhyantara shodhana by Manjistadi kshara basti in yoga basti pattern. Conclusion: Significant reduction was seen in slough and pain. The appearance of granulation tissue was observed. Sthanika dhara with gomutra, which has ushna, teekshna, and lekhana properties, removes slough and improves local circulation. Sphatika jala does lekhana and shodhana. Panchavalkala kwatha has vrana ropana property. Manjistadi kshara basti does srotoshodhana and enhances circulation by virtue of its kshareeya guna and acts as rakta prasadaka and vrana ropaka.","PeriodicalId":14253,"journal":{"name":"International journal of research in ayurveda and pharmacy","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136035015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International journal of research in ayurveda and pharmacy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1